An Immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901

Josue Antonio Estrada, Chien-Yu Cheng, Shin-Yen Ku, Hui-Chun Hu, Hsiu-Wen Yeh, Yi-Chun Lin, Cheng-Pin Chen, Shu-Hsing Cheng, I-Feng Lin
doi: https://doi.org/10.1101/2022.02.26.22271364

Data Availability

All data produced in the study are available upon reasonable request to the authors

Back to top
Posted March 01, 2022.
Download PDF
Data/Code
Email
An Immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
Josue Antonio Estrada, Chien-Yu Cheng, Shin-Yen Ku, Hui-Chun Hu, Hsiu-Wen Yeh, Yi-Chun Lin, Cheng-Pin Chen, Shu-Hsing Cheng, I-Feng Lin
medRxiv 2022.02.26.22271364; doi: https://doi.org/10.1101/2022.02.26.22271364
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area